Can biotechnology save the developing world?
Learn how the industry hopes to ease the burden of disease, secure the food supply, and provide more affordable energy.

Connect and develop with Procter & Gamble Pharmaceuticals, the sponsor of the debut issue of the magazine.

In the battle to stop a disease that kills millions every year, delivery via inhalation could prevail. BY MYRNA E. WATANABE

Read More

Blending Behavior and Biotech to Fight HIV/AIDS

Can Uganda go beyond its ABCs to vaccines?
BY MEREDITH SMALL

Growing Energy in Kenya

Can the country’s biofuel efforts serve as a model for developing nations?
BY STEVE MBOGO

Debugging Developing-World Cotton

Will genetically modified cotton turn tragedy into triumph? BY CORMAC SHERIDAN

10 Unsung Biotech Heroes

Introducing some of the lesser-known leaders that use biotechnology to improve the developing world.

Could Wheat Rust Away?

An new scourge could wreak havoc on wheat BY MIKE MAY

Stem Cell Survey

Recent clinical trials reveal a number of therapeutics under development for a range of diseases BY KENDALL MORGAN

The Full Monty on Drug Targets

Receptoromics can uncover potential side effects and novel targets BY MANASEE WAGH

Dialing for Health in Africa

How cell phones are helping track HIV/AIDS, first in Rwanda, and hopefully in 10 more African countries BY MANASEE WAGH

Nanotech Weaving a Safer Web

Is spider silk really stronger than Kevlar? BY MANASEE WAGH


Microbial Fuel Cells as a Power Outlet?

Considerable improvements are still needed for this nascent field.

Growing Biotech in the Cornbelt

Nebraska is a fertile biotech environment BY MANASEE WAGH

Restoring a Stem Cell Reputation

South Korea is spending huge amounts of money to revamp it’s image; will that do the job? BY MIKE MAY

A Bloody Battle

Two drug giants fight to conquer anemia BY MANASEE WAGH


Fluid Flow at the Nano Level

Understanding water in microchannels and nanochannels BY MIKE MAY

A Biotech Call to Arms

It's time for industry to stop leaving NIH funding advocacy to others BY GREGORY T. LUCIER


Regulatory Reactions

What can be learned from Europe's regulation of biogenerics? BY MARK SENAK

Start It Up

Use your grantwriting skills to turn an idea into a company BY RAM SASISEKHARAN


Biotechs See the Lights

Can the Diamond Light Source - the world's newest and brightest synchrotron - attract industrial users? BY MICHAEL KENWARD

Café Biotech

Computing the social science reveals the dynamics behind biotechnology clusters BY STEVEN CASPAR



A Venture-Capital Adventure

How an effort to produce antibodies took an immunologist on a rollercoaster ride of financing BY PETER GWYNNE

What are Friends For?

Using your connections to fund a start-up BY TED AGRES

Following the Basics Enhances Forecasting

Five things not to forget when forecasting BY KEN WILAN


Eight Ingredients to Build a Life Sciences Hub

ELNs improve quality control and enable easy data sharing; do you need it? BY MELISSA LEE PHILLIPS

RNAi: Tips to Better Silencing

BY AILEEN CONSTANS


Do You Need an Electronic Lab Notebook?

ELNs improve quality control and enable easy data sharing; do you need it? BY MELISSA LEE PHILLIPS

The 5 Spot

A biotech blogger picks his Top-5 must-must-read blogs BY YALI FRIEDMAN


Going with the Flow in Software

Trends in workflow & LIMS applications BY MIKE MAY


What Can the Biotech Industry Learn from a Consumer Products Giant? Find out from Mark Collar, President of Global Pharmaceuticals & Personal Health at P&G.

A Day in the Life: Search and Evaluate

Meet Bhavani, who crisscrosses the globe in search of novel compounds.

A Day in the Life: A Personal Touch Meet Dave, who is one of the architects of P&G renowned alliance management capability

A Day in the Life: From Drawing Board to the Pharmacy

Meet Kevin, who guides a products' journey from clinical development to marketing.

Secrets to Successful Alliances

Get expert tips on how to find the right partner and build a mutually beneficial alliance.


Frank Reflections on Building a Biotech Partnership

A Q&A with ARYx CEO, Paul Goddard, who talks about giving birth to an alliance.